Global Spine Biologics Market Analysis & Research 2018 by Leading Countries, News, Growth, Drivers, Risks, Opportunities, Forecast, Top Vendors Analysis and Forecast to 2024

Spine Biologics
The report “Global Spine Biologics Market – Trends and Forecast to 2024” includes company share analysis for the major companies operating in this market by major regions North America, Europe and Asia Pacific. The details of mergers & acquisitions, product launches, expansions, and product life cycle matrix is also a part of this report.

Global Spine Biologics Market By Product (Bone Allografts, Bone Graft Substitute, Platelet Rich Plasma, Bone Marrow Aspirate Therapy), By End-User (Hospitals, Spinal Surgery Centers, Orthopedic Clinics, Others), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World)

Report Analysis:

The global spine biologics market is expected to reach USD 2.7 billion by 2024 at a CAGR of 4.4% from 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Download exclusive PDF sample report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-spine-biologics-market

Top Key Players:

  • Arthrex, Inc.
  • Cesca Therapeutics, Inc.
  • DepuySynthes, Inc.
  • DMP Spine
  • Exactech, Inc.
  • K2m, Inc.
  • Lattice Biologics
  • Medtronic
  • Nuo Therapeutics, Inc.
  • Nutech
  • Nuvasive, Inc.
  • Orthofix Holdings, Inc.
  • Regen Lab Sa
  • RTI Surgical, Inc.
  • Stryker Corporation
  • Wright Medical Technology, Inc.
  • X-Spine Systems, Inc.
  • Zimmer Holdings, Inc.

Get 10% Discount Instant Mail us @ sopan.gedam@databridgemarketresearch.com

Key Factors:

Biologics assist the natural process of bone formation. They can also be used as products that can cure the diseaseor degenerated discs. Biologics for spine includes all the biological materials that play a role in a spinal procedure;these are one of the most innovative advances in spine surgical treatment. These are implants used in lieuallografts or as a support for bones in and around the spinal region.

Conventionally, allografts were considered as a gold standard for replenishment of the spinal bones. However,drawbacks such as donor site complications, high surgical cost, lengthy surgical procedures, and longer recovery time resulted in a shift from allograft bones to other biological alternatives, such as BMP, DBM, and bone substitutes. BMPs are proteins that are considered as essential in bone formation. They stimulate the process ofbone growth and spinal fusion. They offer advantages such as minimal postoperative pain, shorter hospital stays,faster recovery, in addition to eliminating the need of harvesting bone from patient. Currently, clinical investigation in order to increase its application in spine degenerative disc surgery is in process. Another, common bone graft substitute is Demineralized Bone Matrix (DBM), derived from cadaver bone graft. They are available in various forms, such as putty, powder, gel, or chips.

This growth in the market is driven by rising incidence of spinal disorders, rising healthcare expenditure in developing nations owing to growing income levels, rising obesity cases, awareness on the newly developed spine treatment techniques and devices, technological advancements, and rising demand of minimally invasive spine surgeries. However, the major restraints include scarcity of expertise, lack of patient awareness, and cost of surgery and reimbursement scenario.

Report Segmentation:

The report – Global Spine Biologics Market is analyzed and segmented on the basis of product, surgery type and geography.

The product segment is categorized into:

  • Bone Allografts
  • Bone Graft Substitute
  • Platelet Rich Plasma
  • Bone Marrow Aspirate Therapy

Bone grafts; bone graft substitutes; platelet-rich plasma (PRP) and bone marrow aspirate therapy among others. The surgery type segment is categorized into Anterior Cervical Discectomy and Fusion (ACDF); Transforamenal Lumbar Interbody Fusion (TLIF); Anterior Lumbar Interbody Fusion (ALIF); Lateral Lumbar Interbody Fusion (LLIF) among others.

On the basis of End-User:

  • Hospitals
  • Spinal Surgery Centers
  • Orthopedic Clinics
  • Others

On the basis of region:

  • North America
  • Europe
  • South America
  • Asia-Pacific
  • Rest of the World (RoW)

North America contributed the largest share of 69.3% to the global spine biologics market, followed by Europe. The North American spine biologics market has witnessed significant growth in the recent years, as a result of the increased population, rise in awareness of newly developed technologies, increased per capita income, and improved medical literacy and tourism, among others. The increasing ageing population and growing health concerns have led governments across the region to take several initiatives, thereby resulting in growth in the market.

Download Detailed TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-spine-biologics-market

Table of Contents:

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. MARKET LANDSCAPE SUMMARY

4. PREMIUM INSIGHTS

5. SPINE BIOLOGICS MARKET, BY PRODUCT TYPE

6. SPINE BIOLOGICS MARKET, BY SURGERY TYPE

7. SPINE BIOLOGICS MARKET, BY END USER

8. SPINE BIOLOGICS MARKET, BY GEOGRAPHY

9. SPINE BIOLOGICS MARKET: COMPETITIVE LANDSCAPE

10. SPINE BIOLOGICS MARKET, COMPANY PROFILES

11. APPENDIX

12. ABOUT DATA BRIDGE MARKET RESEARCH

Frequently Asked Questions:

  • What will the market size be in 2024?
  • What are the key factors driving the global market?
  • What are the challenges to market growth?
  • Who are the key players in the market?
  • What are the market opportunities and threats faced by the key players?
  • What will be the growth rate in 2024?
  • Which strategies are used by top players in the Global Spine Biologics Market?

Order a copy of Global Spine Biologics Market Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-spine-biologics-market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact:

Sopan Gedam

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sopan.gedam@databridgemarketresearch.com

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Sopan Gedam
Email: Send Email
Phone: +1-888-387-2818
Address:Office Number 402, Amanora Chambers, Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://databridgemarketresearch.com/reports/global-spine-biologics-market/